NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation P Hruz, AS Zinkernagel, G Jenikova, GJ Botwin, JP Hugot, M Karin, ... Proceedings of the National Academy of Sciences 106 (31), 12873-12878, 2009 | 235 | 2009 |
Adverse events after SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease GJ Botwin, D Li, J Figueiredo, S Cheng, J Braun, DPB McGovern, ... Official journal of the American College of Gastroenterology| ACG 116 (8 …, 2021 | 96 | 2021 |
Genome‐wide association study and meta‐analysis on alcohol‐associated liver cirrhosis identifies genetic risk factors TH Schwantes‐An, R Darlay, P Mathurin, S Masson, S Liangpunsakul, ... Hepatology 73 (5), 1920-1931, 2021 | 76 | 2021 |
Antibody responses after SARS-CoV-2 mRNA vaccination in adults with inflammatory bowel disease GY Melmed, GJ Botwin, K Sobhani, D Li, J Prostko, J Figueiredo, S Cheng, ... Annals of internal medicine 174 (12), 1768-1770, 2021 | 69 | 2021 |
Altered intestinal ACE2 levels are associated with inflammation, severe disease, and response to anti-cytokine therapy in inflammatory bowel disease AA Potdar, S Dube, T Naito, K Li, G Botwin, T Haritunians, D Li, D Casero, ... Gastroenterology 160 (3), 809-822. e7, 2021 | 54 | 2021 |
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers JB Whitfield, TH Schwantes-An, R Darlay, GP Aithal, SR Atkinson, ... Journal of hepatology 76 (2), 275-282, 2022 | 52 | 2022 |
Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients E Izquierdo, P Proszek, G Pericoli, S Temelso, M Clarke, DM Carvalho, ... Neuro-oncology advances 3 (1), vdab013, 2021 | 52 | 2021 |
Evaluation of direct-to-consumer low-volume lab tests in healthy adults BA Kidd, G Hoffman, N Zimmerman, L Li, JW Morgan, PK Glowe, ... The Journal of clinical investigation 126 (5), 1734-1744, 2016 | 46 | 2016 |
Brief Report: Genetics of Alcoholic Cirrhosis—G enom ALC Multinational Study JB Whitfield, K Rahman, PS Haber, CP Day, S Masson, AK Daly, ... Alcoholism: Clinical and Experimental Research 39 (5), 836-842, 2015 | 42 | 2015 |
The T-cell response to SARS-CoV-2 vaccination in inflammatory bowel disease is augmented with anti-TNF therapy D Li, A Xu, E Mengesha, R Elyanow, RM Gittelman, H Chapman, ... Inflammatory bowel diseases 28 (7), 1130-1133, 2022 | 38* | 2022 |
Decreased antibody responses to Ad26. COV2. S relative to SARS-CoV-2 mRNA vaccines in patients with inflammatory bowel disease V Pozdnyakova, GJ Botwin, K Sobhani, J Prostko, J Braun, ... Gastroenterology 161 (6), 2041-2043. e1, 2021 | 34 | 2021 |
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study JE Ebinger, GJ Botwin, CM Albert, M Alotaibi, M Arditi, AH Berg, A Binek, ... BMJ open 11 (2), e043584, 2021 | 32 | 2021 |
Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease AA Potdar, S Dube, T Naito, G Botwin, T Haritunians, D Li, S Yang, ... medRxiv, 2020 | 27 | 2020 |
Estimating the scale of COVID-19 epidemic in the United States: Simulations based on air traffic directly from Wuhan, China D Li, J Lv, G Bowtin, J Braun, W Cao, L Li, DPB McGovern MedRxiv, 2020.03. 06.20031880, 2020 | 22 | 2020 |
Bacterial infections in cirrhosis GJ Botwin, TR Morgan Hepatology international 8, 467-474, 2014 | 22 | 2014 |
Serum analyte profiles associated with Crohn’s disease and disease location G Boucher, A Paradis, G Chabot-Roy, L Coderre, EE Hillhouse, A Bitton, ... Inflammatory bowel diseases 28 (1), 9-20, 2022 | 14 | 2022 |
Prevalence and effect of genetic risk of thromboembolic disease in inflammatory bowel disease T Naito, GJ Botwin, T Haritunians, D Li, S Yang, M Khrom, J Braun, J Cho, ... Gastroenterology 160 (3), 771-780. e4, 2021 | 13 | 2021 |
A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis JA Tayek, AA Stolz, DV Nguyen, MW Fleischman, JA Donovan, JM Alcorn, ... EClinicalMedicine 54, 2022 | 12 | 2022 |
Update on recently approved treatments for hepatitis C D Chao, GJ Botwin, TR Morgan Current treatment options in gastroenterology 12, 211-228, 2014 | 10 | 2014 |
Symptomology following mRNA vaccination against SARS-CoV-2 JE Ebinger, R Lan, N Sun, M Wu, S Joung, GJ Botwin, P Botting, ... Preventive medicine 153, 106860, 2021 | 9 | 2021 |